Related Experiment Video
Updated: Jun 22, 2025
10:32
Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
Published on: June 5, 2015
18.4K
Non B Cell-Derived Immunoglobulin, A Brighter Horizon for the Future
Ming Chu1, Ning Fu2, Liang Zhang3
1Department of Immunology, School of Basic Medical Sciences, Peking University, Beijing, China. famous@bjmu.edu.cn.
Advances in Experimental Medicine and Biology
|July 5, 2024
Summary
Immunoglobulin (Ig) is traditionally known to be produced by B cells. However, non-B cell-derived Igs exhibit diverse biological functions, impacting immunology and diseases like cancer.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- The established immunological theory posits that Immunoglobulin (Ig) production is exclusive to B lymphocytes, mediating antibody functions.
- Recent discoveries reveal non-B cell-derived Igs (non-B-Igs) with multifaceted biological activities beyond traditional antibody functions.
- These findings challenge the canonical understanding of Ig origins and functions.
Purpose of the Study:
- To re-evaluate the classic concept of Immunoglobulin (Ig) in light of non-B cell-derived Igs.
- To explore the structural, genetic, and functional characteristics of non-B-Igs.
- To investigate the role of non-B-Igs in various clinical conditions, including cancer.
Main Methods:
- Comparative analysis of Ig structures and genetic regulation between B cell-derived and non-B cell-derived Igs.
- Functional assays to determine the biological activities of non-B-Igs.
- Clinical data analysis correlating non-B-Ig presence with disease manifestations.
Main Results:
- Non-B-Igs possess distinct structural and regulatory features compared to conventional Igs.
- These non-B-Igs demonstrate a range of biological activities, including roles in inflammation, autoimmune diseases, and anaphylaxis.
- A significant finding is the direct promotion of malignant tumor occurrence by non-B-Igs.
Conclusions:
- The discovery of non-B-Igs necessitates a paradigm shift in basic immunology and our understanding of Ig-related diseases.
- Non-B-Igs represent a novel factor in the pathogenesis of autoimmune diseases, chronic inflammation, and anaphylaxis.
- Non-B-Igs emerge as potential direct contributors to cancer development, opening new avenues for research and therapeutic strategies.
More Related Videos
13:14Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
Published on: February 6, 2018
10.4K
00:09Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations
Published on: August 22, 2019
10.7K
Related Concept Videos
01:31Hybridoma Technology
14.4K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.4K
01:24B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
01:10Antibody Structure
59.8K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
59.8K
01:25Antibody Structure and Classes
871
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
871
01:22Development of Immunocompetence
300
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
300